Literature DB >> 4857531

Response of Paget's disease to porcine and salmon calcitonins: effects of long-term treatment.

J DeRose, F R Singer, A Avramides, A Flores, R Dziadiw, R K Baker, S Wallach.   

Abstract

Mesh:

Substances:

Year:  1974        PMID: 4857531     DOI: 10.1016/0002-9343(74)90815-8

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  31 in total

Review 1.  Calcitonin and calcitonin receptors: bone and beyond.

Authors:  M Pondel
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

2.  Medical staff conference. Paget disease of bone.

Authors: 
Journal:  West J Med       Date:  1978-09

3.  Treatment of Paget's disease of bone with once a week injections of salmon calcitonin.

Authors:  A Avramides; A Flores; J Derose; S Wallach
Journal:  Br Med J       Date:  1975-09-13

4.  Formation of neutralizing antibodies during intranasal synthetic salmon calcitonin treatment of postmenopausal osteoporosis.

Authors:  R Muff; M A Dambacher; J A Fischer
Journal:  Osteoporos Int       Date:  1991-02       Impact factor: 4.507

5.  Treatment of Paget's disease of bone with a combination of intranasal salmon calcitonin and oral calcium and thiazide.

Authors:  R A Evans; N M Somers; C R Dunstan; E Hills; M Evans
Journal:  Calcif Tissue Int       Date:  1991-09       Impact factor: 4.333

6.  High-dose pamidronate in the management of resistant Paget's disease.

Authors:  T Cundy; D Wattie; A R King
Journal:  Calcif Tissue Int       Date:  1996-01       Impact factor: 4.333

7.  The possible role of calcitonin deficiency in the development of bone disease due to chronic renal failure.

Authors:  J A Kanis; M Earnshaw; G Heynen; R G Russell; C G Woods
Journal:  Calcif Tissue Res       Date:  1977-05

Review 8.  Treating Paget's disease.

Authors:  D A Heath
Journal:  Br Med J (Clin Res Ed)       Date:  1987-04-25

Review 9.  Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use.

Authors:  S Patel; A R Lyons; D J Hosking
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

10.  Pamidronate is effective for Paget's disease of bone refractory to conventional therapy.

Authors:  S J Wimalawansa; R D Gunasekera
Journal:  Calcif Tissue Int       Date:  1993-10       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.